Osteogenic differentiation of intact human amniotic membrane

Biomaterials

Volumn 31, Issue 33, 2010, Pages 8659-8665

  Lindenmair, Andrea ^a,c   Wolbank, Susanne ^a,c   Stadler, Guido ^a,c   Meinl, Alexandra ^a,c,d   Peterbauer Scherb, Anja ^b,c   Eibl, Johann ^e   Polin, Helene ^b   Gabriel, Christian ^b,c   van Griensven, Martijn ^a,c   Redl, Heinz ^a,c  

^a LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^b Red Cross Blood Transfusion Service of Upper Austria   (Austria)

^c Austrian Cluster for Tissue Regeneration ^*  (Austria)

^d Bernhard Gottlieb University Clinic of Dentistry   (Austria)

^e Bio Products and Bio Engineering AG   (Austria)

Author keywords

Biomineralization; Bone tissue engineering; Human amniotic membrane; Osteogenesis; Sessile stem cells

Indexed keywords

ALKALINE PHOSPHATASE; AMNIOTIC MEMBRANES; BONE MORPHOGENETIC PROTEINS; BONE TISSUE ENGINEERING; CALCIUM CONTENT; CELL ISOLATION; CONTROL MEDIUMS; CONVENTIONAL APPROACH; IN-VITRO; MRNA EXPRESSION; NATURAL ENVIRONMENTS; OSTEOCALCIN; OSTEOGENESIS; OSTEOGENIC; OSTEOGENIC DIFFERENTIATION; OSTEOGENIC MEDIA; OSTEOPONTIN; STEM CELL;

BIOCHEMISTRY; BIOLOGICAL MATERIALS; BIOMATERIALS; BIOMINERALIZATION; BIOPSY; BONE; CALCIUM; OCEAN HABITATS; PHOSPHATASES; PROTEINS; TISSUE ENGINEERING;

STEM CELLS;

ALKALINE PHOSPHATASE; BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CALCIUM; MESSENGER RNA; OSTEOCALCIN; OSTEOPONTIN; TRANSCRIPTION FACTOR RUNX2;

AMNION; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MINERALIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; STEM CELL; TISSUE ENGINEERING;

ALKALINE PHOSPHATASE; AMNION; BIOLOGICAL MARKERS; CALCIUM; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SPACE; OSTEOGENESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77957312278     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.07.090     Document Type: Article

References (49)

1. Hao Y., Ma D.H., Hwang D.G., Kim W.S., Zhang F. Identification of antiangiogenic and antiinflammatory proteins in human amniotic membrane. Cornea 2000, 19(3):348-352.
2. Dua H.S., Gomes J.A., King A.J., Maharajan V.S. The amniotic membrane in ophthalmology. Surv Ophthalmol 2004, 49(1):51-77.
3. Ganatra M.A. Amniotic membrane in surgery. J Pak Med Assoc 2003, 53(1):29-32.
4. Gomes J.A., Romano A., Santos M.S., Dua H.S. Amniotic membrane use in ophthalmology. Curr Opin Ophthalmol 2005, 16(4):233-240.
5. Adinolfi M., Akle C.A., McColl I., Fensom A.H., Tansley L., Connolly P., et al. Expression of HLA antigens, beta 2-microglobulin and enzymes by human amniotic epithelial cells. Nature 1982, 295(5847):325-327.
6. Akle C.A., Adinolfi M., Welsh K.I., Leibowitz S., McColl I. Immunogenicity of human amniotic epithelial cells after transplantation into volunteers. Lancet 1981, 2(8254):1003-1005.
7. Faulk W.P., Matthews R., Stevens P.J., Bennett J.P., Burgos H., Hsi B.L. Human amnion as an adjunct in wound healing. Lancet 1980, 1(8179):1156-1158.
8. Gajiwala K., Gajiwala A.L. Evaluation of lyophilised, gamma-irradiated amnion as a biological dressing. Cell Tissue Bank 2004, 5(2):73-80.
9. Gruss J.S., Jirsch D.W. Human amniotic membrane: a versatile wound dressing. Can Med Assoc J 1978, 118(10):1237-1246.
10. Subrahmanyam M. Amniotic membrane as a cover for microskin grafts. Br J Plast Surg 1995, 48(7):477-478.
11. Ward D.J., Bennett J.P., Burgos H., Fabre J. The healing of chronic venous leg ulcers with prepared human amnion. Br J Plast Surg 1989, 42(4):463-467.
12. Tosi G.M., Massaro-Giordano M., Caporossi A., Toti P. Amniotic membrane transplantation in ocular surface disorders. J Cell Physiol 2005, 202(3):849-851.
13. Kim J.C., Tseng S.C. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 1995, 14(5):473-484.
14. Dhall K. Amnion graft for treatment of congenital absence of the vagina. Br J Obstet Gynaecol 1984, 91(3):279-282.
15. Nisolle M., Donnez J. Vaginoplasty using amniotic membranes in cases of vaginal agenesis or after vaginectomy. J Gynecol Surg 1992, 8(1):25-30.
16. Zohar Y., Talmi Y.P., Finkelstein Y., Shvili Y., Sadov R., Laurian N. Use of human amniotic membrane in otolaryngologic practice. Laryngoscope 1987, 97(8 Pt 1):978-980.
17. Arora M., Jaroudi K.A., Hamilton C.J., Dayel F. Controlled comparison of interceed and amniotic membrane graft in the prevention of postoperative adhesions in the rabbit uterine horn model. Eur J Obstet Gynecol Reprod Biol 1994, 55(3):179-182.
18. Rennekampff H.O., Dohrmann P., Fory R., Fandrich F. Evaluation of amniotic membrane as adhesion prophylaxis in a novel surgical gastroschisis model. J Invest Surg 1994, 7(3):187-193.
19. Young R.L., Cota J., Zund G., Mason B.A., Wheeler J.M. The use of an amniotic membrane graft to prevent postoperative adhesions. Fertil Steril 1991, 55(3):624-628.
20. He Q., Li Q., Chen B., Wang Z. Repair of flexor tendon defects of rabbit with tissue engineering method. Chin J Traumatol 2002, 5(4):200-208.
21. Mligiliche N., Endo K., Okamoto K., Fujimoto E., Ide C. Extracellular matrix of human amnion manufactured into tubes as conduits for peripheral nerve regeneration. J Biomed Mater Res 2002, 63(5):591-600.
22. Parolini O., Alviano F., Bagnara G.P., Bilic G., Buhring H.J., Evangelista M., et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international workshop on placenta derived stem cells. Stem Cells 2008, 26(2):300-311.
23. Miki T., Lehmann T., Cai H., Stolz D.B., Strom S.C. Stem cell characteristics of amniotic epithelial cells. Stem Cells 2005, 23(10):1549-1559.
24. Portmann-Lanz C.B., Schoeberlein A., Huber A., Sager R., Malek A., Holzgreve W., et al. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Am J Obstet Gynecol 2006, 194(3):664-673.
25. Sakuragawa N., Kakinuma K., Kikuchi A., Okano H., Uchida S., Kamo I., et al. Human amnion mesenchyme cells express phenotypes of neuroglial progenitor cells. J Neurosci Res 2004, 78(2):208-214.
26. Wolbank S., Peterbauer A., Fahrner M., Hennerbichler S., van Griensven M., Stadler G., et al. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 2007, 13(6):1173-1183.
27. Zhao P., Ise H., Hongo M., Ota M., Konishi I., Nikaido T. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 2005, 79(5):528-535.
28. Stadler G., Hennerbichler S., Lindenmair A., Peterbauer A., Hofer K., van Griensven M., et al. Phenotypic shift of human amniotic epithelial cells in culture is associated with reduced osteogenic differentiation in vitro. Cytotherapy 2008, 10(7):743-752.
29. Magatti M., De Munari S., Vertua E., Gibelli L., Wengler G.S., Parolini O. Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities. Stem Cells 2008, 26(1):182-192.
30. Magatti M., De Munari S., Vertua E., Nassauto C., Albertini A., Wengler G.S., et al. Amniotic mesenchymal tissue cells inhibit dendritic cell differentiation of peripheral blood and amnion resident monocytes. Cell Transplant 2009, 18(8):899-914.
31. Sakuragawa N., Yoshikawa H., Sasaki M. Amniotic tissue transplantation: clinical and biochemical evaluations for some lysosomal storage diseases. Brain Dev 1992, 14(1):7-11.
32. Scaggiante B., Pineschi A., Sustersich M., Andolina M., Agosti E., Romeo D. Successful therapy of Niemann-Pick disease by implantation of human amniotic membrane. Transplantation 1987, 44(1):59-61.
33. Tylki-Szymanska A., Maciejko D., Kidawa M., Jablonska-Budaj U., Czartoryska B. Amniotic tissue transplantation as a trial of treatment in some lysosomal storage diseases. J Inherit Metab Dis 1985, 8(3):101-104.
34. Yeager A.M., Singer H.S., Buck J.R., Matalon R., Brennan S., O'Toole S.O., et al. A therapeutic trial of amniotic epithelial cell implantation in patients with lysosomal storage diseases. Am J Med Genet 1985, 22(2):347-355.
35. Yang J., Yamato M., Nishida K., Ohki T., Kanzaki M., Sekine H., et al. Cell delivery in regenerative medicine: the cell sheet engineering approach. J Control Release 2006, 116(2):193-203.
36. Miyahara Y., Nagaya N., Kataoka M., Yanagawa B., Tanaka K., Hao H., et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006, 12(4):459-465.
37. Hennerbichler S., Reichl B., Pleiner D., Gabriel C., Eibl J., Redl H. The influence of various storage conditions on cell viability in amniotic membrane. Cell Tissue Bank 2007, 8(1):1-8.
38. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284(5411):143-147.
39. Smith A.R., Visioli F., Hagen T.M. Vitamin C matters: increased oxidative stress in cultured human aortic endothelial cells without supplemental ascorbic acid. FASEB J 2002, 16(9):1102-1104.
40. Sugimoto M., Okugawa Y., Miwa N. Preventive effects of phosphorylated ascorbate on ultraviolet-B induced apoptotic cell death and DNA strand cleavage through enrichment of intracellular vitamin C in skin epidermal keratinocytes. Free Radic Res 2006, 40(2):213-221.
41. Rossig L., Hoffmann J., Hugel B., Mallat Z., Haase A., Freyssinet J.M., et al. Vitamin C inhibits endothelial cell apoptosis in congestive heart failure. Circulation 2001, 104(18):2182-2187.
42. Esteban M.A., Wang T., Qin B., Yang J., Qin D., Cai J., et al. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell. 2010, 6(1):71-79.
43. Wilshaw S.P., Kearney J., Fisher J., Ingham E. Biocompatibility and potential of acellular human amniotic membrane to support the attachment and proliferation of allogeneic cells. Tissue Eng Part A 2008, 14(4):463-472.
44. Bilic G., Zeisberger S.M., Mallik A.S., Zimmermann R., Zisch A.H. Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy. Cell Transplant 2008, 17(8):955-968.
45. Beresford J.N., Joyner C.J., Devlin C., Triffitt J.T. The effects of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro. Arch Oral Biol 1994, 39(11):941-947.
46. Johnson G.A., Burghardt R.C., Bazer F.W., Spencer T.E. Osteopontin: roles in implantation and placentation. Biol Reprod 2003, 69(5):1458-1471.
47. Speer M.Y., Chien Y.C., Quan M., Yang H.Y., Vali H., McKee M.D., et al. Smooth muscle cells deficient in osteopontin have enhanced susceptibility to calcification in vitro. Cardiovasc Res 2005, 66(2):324-333.
48. Kim G.J., Romero R., Kuivaniemi H., Tromp G., Haddad R., Kim Y.M., et al. Expression of bone morphogenetic protein 2 in normal spontaneous labor at term, preterm labor, and preterm premature rupture of membranes. Am J Obstet Gynecol 2005, 193(3 Pt 2):1137-1143.
49. Raida M., Heymann A.C., Gunther C., Niederwieser D. Role of bone morphogenetic protein 2 in the crosstalk between endothelial progenitor cells and mesenchymal stem cells. Int J Mol Med 2006, 18(4):735-739.